Growing community of inventors

Roscoff, France

Karima Bettayeb

Average Co-Inventor Count = 5.62

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Karima BettayebLaurent Meijer (3 patents)Karima BettayebNassima Oumata (2 patents)Karima BettayebHerve Galons (1 patent)Karima BettayebHervé Galons (1 patent)Karima BettayebChristian Berthou (1 patent)Karima BettayebLuc Demange (1 patent)Karima BettayebKarine Lester (1 patent)Karima BettayebAlexios-Le-Andros Skaltsounis (1 patent)Karima BettayebProkopios Maglatis (1 patent)Karima BettayebJacint Boix (1 patent)Karima BettayebJudit Ribas (1 patent)Karima BettayebKarima Bettayeb (3 patents)Laurent MeijerLaurent Meijer (23 patents)Nassima OumataNassima Oumata (5 patents)Herve GalonsHerve Galons (5 patents)Hervé GalonsHervé Galons (3 patents)Christian BerthouChristian Berthou (3 patents)Luc DemangeLuc Demange (3 patents)Karine LesterKarine Lester (2 patents)Alexios-Le-Andros SkaltsounisAlexios-Le-Andros Skaltsounis (1 patent)Prokopios MaglatisProkopios Maglatis (1 patent)Jacint BoixJacint Boix (1 patent)Judit RibasJudit Ribas (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Centre National De La Recherche Scientifique (2 from 5,081 patents)

2. Université Paris Descartes (2 from 132 patents)

3. Université De Rennes 1 (2 from 111 patents)

4. Université De Bretagne Occidentale (1 from 38 patents)

5. Centre Nationale De La Recherche Scientifique (1 from 21 patents)

6. Centre Hospitalier Universitaire De Brest (1 from 4 patents)

7. University of Pierre and Marie Curie (paris 6) (1 from 1 patent)

8. University of Rennes 1 (1 from 1 patent)

9. University of Lleida (1 from 1 patent)

10. Universite D'athenes (1 from 1 patent)


3 patents:

1. 8552053 - 7-substituted indirubin-3'oximes and their applications

2. 8450342 - Perharidines as CDK inhibitors

3. 8431583 - Use of purine derivatives for the manufacture of a medicament

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/28/2025
Loading…